Results 251 to 260 of about 6,121,735 (304)
Some of the next articles are maybe not open access.

Tumor necrosis factor alpha in mycobacterial infection

Seminars in Immunology, 2014
Tumor necrosis factor alpha (TNF-α) is a critical immune mediator in protection against and pathology of tuberculosis (TB). TNF-α had been found to be associated with TB when it was originally identified as cachexin and until today TB research continues to unveil novel roles of this cytokine of highest relevance for the disease process and for novel ...
Dorhoi, A., Kaufmann, S.
openaire   +3 more sources

Role of tumor necrosis factor alpha in asthma

Immunology and Allergy Clinics of North America, 2004
Asthma is a heterogeneous disease in which various cytokines orchestrate airway inflammation. Tumor necrosis alpha (TNF-alpha) is a proinflammatory cytokine that has been implicated in the modulation of inflammation in various diseases, including asthma. Although TNF-alpha blocking strategies have been an effective therapeutic modality in diseases such
Babu, K. Suresh   +2 more
openaire   +3 more sources

[Tumor necrosis factor alpha].

Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1992
TNF-alpha (Cachectin) is a cytokine (tissue hormone) synthesized and secreted as a trimeric polypeptide; major producers are the cells of the RES after stimulation, e.g. by endotoxin. Its synthesis is strictly regulated. TNF elicits a great number of cell-specific responses. IL-1 and probably additional mediators cooperate in these effects.
C S, Rock, S F, Lowry
openaire   +3 more sources

Production of Tumor Necrosis Factor Alpha and Hemodialysis

Nephron, 2008
The production of TNFα by peripheral blood mononuclear cells (PBMC) was determined in 18 hemodialysis (HD) patients. Blood was taken from each patient before and after an HD treatment. Both pre- and post-HD PBMC produced significantly more TNFα than controls (TNFα units/ml; mean ± SEM; controls 3.1 ± 0.7; pre-HD 9.7 ± 3.9; post-HD 19.8 ± 7.7, p < 0 ...
C, Macdonald   +3 more
openaire   +2 more sources

Serum Tumor Necrosis Factor-Alpha in Neonatal Sepsis

American Journal of Perinatology, 1997
Tumor necrosis factor-alpha (TNF-alpha) is thought to be an important mediator in the pathogenesis of neonatal septicemia. To assess the role of TNF-alpha in neonatal sepsis, serum levels of TNF-alpha were measured in a group of neonates with septicemia and compared with the levels of gestational-postnatal, age-matched healthy controls.
Atici A.   +3 more
openaire   +3 more sources

Tumor Necrosis Factor-Alpha Antagonist-Induced Sarcoidosis

JCR: Journal of Clinical Rheumatology, 2010
Sarcoidosis is a multisystem granulomatous disease of unknown etiology. Tumor necrosis factor (TNF)-alpha is an important player in granuloma formation, and recent clinical trials have investigated the efficacy of TNF-alpha inhibitors in sarcoidosis. Paradoxically, there are several case reports in the medical literature describing the development of ...
Clementine, Rochelle Robicheaux   +5 more
openaire   +5 more sources

Bioassay for Tumor Necrosis Factors-alpha and -beta

Molecular Biotechnology, 2000
Tumor necrosis factor (TNF) is a central cytokine in the pathogenesis of septic shock and other inflammatory states. Assay by immunoassay is convenient, but, because of circulating soluble receptors, does not accurately reflect biological activity of the cytokine.
openaire   +2 more sources

Four epitopes on tumor necrosis factor-alpha defined by murine anti-tumor necrosis factor-alpha monoclonal antibodies

Immunology Letters, 1994
Eight murine anti-TNF alpha monoclonal antibodies (mAb) were produced after immunization of BALB/c mice with rhTNF alpha. Six of these mAbs were able to neutralize cytotoxic activity of TNF alpha against L929 cells. Two other mAbs had no neutralizing effect. Epitope mapping studies were performed by ELISA and by using a BIAcore system (Pharmacia).
B, Karim   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy